Uppsala

• An open-label, prospective, randomised, cross-over trial to assess the pharmacokinetics of an amorphous formulation of sorafenib in mesoporo … Not authorised
  2024-514496-18-00 3 Hepatocellular carcinoma, renal cell carcinoma and differentiated thyr
• A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc … Unknown
  2022-502779-40-99 5 Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
• Prophylactic Treatment of Graves Ophthalmopathy (GO) in Newly Diagnosed Graves' Disease (GD) with Atorvastatin (ATORGO) Pending
  2023-504654-35-00 4 Graves Ofthalmopathy
• Phase 2 randomised study of Radspherin® in patients with peritoneal carcinomatosis from colorectal carcinoma after cytoreductive surgery (CR … Pending
  2023-508496-37-00 4 Carcinomatosis of peritoneal cavity
• A research study on how well cagrilintide and CagriSema work in children and adolescents with excess body weight Pending
  2023-509176-42-00 11 Obesity and T2D
• IntReALL BCP 2020 – International Study for Treatment of Childhood Relapsed Precursor B-cell ALL 2020 Pending
  2023-509392-17-00 5 Relapsed Acute Lymphoblastic Leukemia (ALL)
• A multicentre, prospective, open-label study with [68Ga]Ga-ABY-025 PET-imaging to characterize HER2-expression and explore the therapy-predi … Pending
  2024-512721-89-00 4 Breast Cancer
• The Synergism Or Long Duration (SOLD) Study Pending
  2024-512884-30-00 5 breast cancer
• GLUTAMICS III Pending
  2024-513575-40-01 5 Acute kidney injury and heart failure after coronary artery bypass sur
• SIOP PNET 5 medulloblastoma Pending
  2024-513724-42-00 10 Medulloblastoma
• ALASCCA-A randomized double-blind placebo-controlled study with ASA treatment in colorectal cancer patients with mutations in the PI3K signa … Pending
  2024-513778-23-00 5 Colon and rectal cancer tumor stage II-III, tumor with somatic alterat
• OSU6162 as add-on in SSRI/SNRI-resistant depression (ODEN): a double-blind, placebo-controlled evaluation of efficacy and safety Pending
  2024-513894-35-00 4 Depression
• A study to evaluate the efficacy of oxaliplatin- or gemcitabine-based chemotherapy after allocation by standard criteria or by genetic marke … Pending
  2024-514682-19-00 5 Resected pancreatic ductal adenocarcinoma
• A double-blind, randomised, placebo-controlled, first-in-human (FIH) Phase I/IIa, multi-centre trial to assess safety, tolerability, and imm … Pending
  2024-515627-10-00 7 generalised myasthenia gravis
• The Swedish Nationwide Clinical Trial to Facilitate Patient Access to Targeted Cancer Treatment based on Biomarker Profiling (FOCU.SE) Pending
  2024-516003-16-00 4 Advanced Cancer
• SGLT2 inhibitor or metformin as standard treatment in early type 2 diabetes (SMARTEST) Pending
  2024-516228-33-00 6 Type 2 Diabetes
• A Phase I trial to investigate the pharmacokinetics and ECG effects of single doses of linaprazan glurate administered as oral tablets to he … Pending
  2024-516261-36-00 3 Erosive Gastroesophageal Reflux Disease (eGERD)
• A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active convent … Pending
  2024-516723-14-00 6 Rheumatoid Arthritis
• Immediate insertion of intrauterine contraception after medical abortion Pending
  2024-517082-16-01 5 Post medical abortion contraception
• Vaginal administration of selective estrogen receptor modulator (Tamoxifen) treatment to improve sexual function for women with breast cance … Pending
  2024-517315-69-00 5 Vulvovaginal atrophy symptoms
• Study of Intravenous ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibros … Pending
  2024-518013-25-00 4 Idiopathic Pulmonary Fibrosis
• An adaptive, randomized, double-blind, single-center, placebo-controlled first-in-human study evaluating safety, tolerability and exposure o … Pending
  2024-518698-32-00 1 Wound healing
• ProFertil Pending
  2024-518977-32-00 5 Breast Cancer, Acute Leukemia, Lymphomas (Hodgkin and non-Hodgkin) ans
• HiHat trial Pending
  2024-519700-28-01 4 Patients with relapsing-remitting multiple sclerosis with less than 10

Showing 1–24 of 349 trials